Milestones in PD genetics
- PMID: 21626549
- DOI: 10.1002/mds.23637
Milestones in PD genetics
Abstract
Over the last 25 years, genetic findings have profoundly changed our views on the etiology of Parkinson's disease. Linkage studies and positional cloning strategies have identified mutations in a number of genes that cause several monogenic autosomal-dominant or autosomal-recessive forms of the disorder. Although most of these Mendelian forms of Parkinson's disease are rare, whole-genome association studies have more recently provided convincing evidence that low-penetrance variants in at least some of these, but also in several other genes, play a direct role in the etiology of the common sporadic disease as well. In addition, rare variants with intermediate-effect strengths in genes such as Gaucher's disease-associated glucocerebrosidase A have been discovered as important risk factors. "Next-generation" sequencing technologies are expected by some to identify many more of these variants. Thus, an increasingly complex network of genes contributing in different ways to disease risk and progression is emerging. These findings may provide the "genetic entry points" to identify molecular targets and readouts necessary to design rational disease-modifying treatments.
Copyright © 2011 Movement Disorder Society.
Similar articles
-
Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects.Prog Brain Res. 2010;183:3-20. doi: 10.1016/S0079-6123(10)83001-8. Prog Brain Res. 2010. PMID: 20696312
-
Parkinson's disease: from monogenic forms to genetic susceptibility factors.Hum Mol Genet. 2009 Apr 15;18(R1):R48-59. doi: 10.1093/hmg/ddp012. Hum Mol Genet. 2009. PMID: 19297401 Review.
-
Role of mendelian genes in "sporadic" Parkinson's disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S66-70. doi: 10.1016/S1353-8020(11)70022-0. Parkinsonism Relat Disord. 2012. PMID: 22166458 Review.
-
What genetics tells us about the causes and mechanisms of Parkinson's disease.Physiol Rev. 2011 Oct;91(4):1161-218. doi: 10.1152/physrev.00022.2010. Physiol Rev. 2011. PMID: 22013209 Review.
-
The role of monogenic genes in idiopathic Parkinson's disease.Neurobiol Dis. 2019 Apr;124:230-239. doi: 10.1016/j.nbd.2018.11.012. Epub 2018 Nov 15. Neurobiol Dis. 2019. PMID: 30448284 Free PMC article. Review.
Cited by
-
PLK2 modulates α-synuclein aggregation in yeast and mammalian cells.Mol Neurobiol. 2013 Dec;48(3):854-62. doi: 10.1007/s12035-013-8473-z. Epub 2013 May 17. Mol Neurobiol. 2013. PMID: 23677647
-
Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases.Aging Dis. 2022 Jul 11;13(4):987-1004. doi: 10.14336/AD.2021.1212. eCollection 2022 Jul 11. Aging Dis. 2022. PMID: 35855336 Free PMC article.
-
Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease.Drugs. 2019 Jul;79(10):1037-1051. doi: 10.1007/s40265-019-01139-4. Drugs. 2019. PMID: 31161537 Review.
-
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.Int J Mol Sci. 2023 Dec 29;25(1):498. doi: 10.3390/ijms25010498. Int J Mol Sci. 2023. PMID: 38203667 Free PMC article. Review.
-
α-Synuclein mutations cluster around a putative protein loop.Neurosci Lett. 2013 Jun 24;546:67-70. doi: 10.1016/j.neulet.2013.04.058. Epub 2013 May 10. Neurosci Lett. 2013. PMID: 23669636 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical